Skip to content

Dual Implant Versus Single Implant Distal End of Femur

Pilot for Dual Implant Versus Single Implant Distal End of Femur (pDISIDE Femur)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06032299
Enrollment
60
Registered
2023-09-11
Start date
2024-04-29
Completion date
2026-11-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femur Fracture

Brief summary

This research study is being conducted to examine the effect of two versus one fixation device for fixation of distal femur fractures.

Interventions

Single implant constructs will be either a retrograde intramedullary nail with interlocking screws or a single plate and screw construct.

PROCEDUREDual Distal Femur Implant

Dual implant constructs will either be an intramedullary nail with an additional plate and screw construct or dual (two plates in any orientation) plate and screw construct.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Femur fracture distal to the femoral diaphysis. * Operative treatment within 72 hours of presenting to the treating hospital. * Patient was previously ambulatory. * Fracture amendable to either single or dual implant fixation. * Informed consent can be obtained from the patient, family member, or power of attorney.

Exclusion criteria

* Associated major lower extremity fracture. * Ongoing infection. * History of metabolic bone disease (Paget's, etc). * Pathologic fracture. * Open fracture. * Severe cognitive impairment (Six Item Screener with 3 or more errors). * Stage 5 Parkinson's disease. * Significant femoral bone loss requiring planned staged bone grafting. * Vascular injury.

Design outcomes

Primary

MeasureTime frameDescription
Number of study-eligible subjectsBaselineTotal number of subjects to be enrolled in the study

Secondary

MeasureTime frameDescription
Operative timesDuration of surgery, approximately 2-4 hoursTotal recorded amount of time in minutes to complete the surgery
Blood lossDuration of surgery, approximately 2-4 hoursTotal amount of surgical blood loss, reported in mL.
Hospitalization daysapproximately 2-3 daysTotal number of days a subject requires hospitalization after surgery
Early post-surgical complications2 weeks post-surgeryNumber of subjects to experience venous thromboembolism (VTE), cardiopulmonary, and/or infectious complications after surgery

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBrandon Yuan, MD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026